Skip to content

Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial

Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01123291
Acronym
ReACT
Enrollment
700
Registered
2010-05-14
Start date
2010-05-31
Completion date
2016-10-31
Last updated
2017-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

follow-up coronary angiography

Brief summary

The purpose of this study is to evaluate the long term clinical impact of routine follow-up coronary angiography after percutaneous coronary intervention (PCI). The primary endpoint is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at 3-year after percutaneous coronary intervention.

Detailed description

Routine follow-up coronary angiography after percutaneous coronary intervention has been performed to detect restenosis in a lot of PCI centers in Japan. On the other hand, previous studies reported that routine follow-up coronary angiography might lead to unnecessary reinterventions in asymptomatic patients. In this situation, the effect of routine follow-up coronary angiography on long-term clinical outcomes remains unknown. The purpose of this study is to evaluate the long-term clinical impact of routine follow-up coronary angiography after PCI compared with clinical follow-up alone. The primary endpoint of this study is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at three-year after percutaneous coronary intervention. The design of this study is almost all-comer design enrolling patients received PCI without any exclusion criteria.

Interventions

PROCEDUREfollow-up coronary angiography

follow-up coronary angiography at 8-12 months after discharge for percutaneous coronary intervention

no routine follow-up coronary angiography at 8-12 months after discharge for percutaneous coronary intervention

Sponsors

Takeshi Morimoto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients received percutaneous coronary intervention * Patients older than 20 years old * Patients who will not scheduled any staged percutaneous coronary intervention

Design outcomes

Primary

MeasureTime frameDescription
a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure4.8 yearsa composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure

Secondary

MeasureTime frameDescription
cardiac death4.8 yearscardiac death
myocardial infarction4.8 yearsmyocardial infarction
stent thrombosis4.8 yearsstent thrombosis defined bya Academic Reseach Consortium
stroke4.8 yearsboth ischemic and hemorrhagic stroke excluding transient ischemic attach
bleeding complications4.8 yearsbleeding complications defined by GUSTO and TIMI
any coronary revascularization4.8 yearsany coronary revascularization
clinically-driven coronary revascularization4.8 yearsclinically-driven coronary revascularization
clinically-driven target-lesion revascularization4.8 yearsclinically-driven target-lesion revascularization
death4.8 yearsdeath
coronary artery bypass grafting4.8 yearscoronary artery bypass grafting
angina4.8 yearsangina
renal function4.8 yearsestimate-glomerular filtration rate
emergency hospitalization for acute coronary syndrome4.8 yearsemergency hospitalization for acute coronary syndrome
hospitalization for congestive heart failure4.8 yearshospitalization for congestive heart failure
composite of cardiac death, myocardial infarction or acute coronary syndrome4.8 yearscomposite of cardiac death, myocardial infarction or acute coronary syndrome
follow-up coronary angiography4.8 yearspresence of follow-up coronary angiography
clinically-driven follow-up coronary angiography4.8 yearspresence of clinically-driven follow-up coronary angiography
any target-lesion revascularization4.8 yearsany target-lesion revascularization

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026